AUDITORY FUNCTION IN PEDIATRIC OSTEO-SARCOMA PATIENTS TREATED WITH MULTIPLE DOSES OF CIS-DIAMMINEDICHLOROPLATINUM(II)

被引：0
作者：
RUIZ, L [1 ]
GILDEN, J [1 ]
JAFFE, N [1 ]
ROBERTSON, R [1 ]
WANG, YM [1 ]
机构：
[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DIV HEAD & NECK SURG,HOUSTON,TX 77030
来源：
CANCER RESEARCH | 1989年 / 49卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：742 / 744
页数：3
相关论文
共 50 条
[31]   CLINICAL-RESPONSE AND TOXICITY WITH CIS-PLATINUM IN PEDIATRIC GERM-CELL TUMORS, HEPATOBLASTOMA AND OSTEO-SARCOMA [J].
TOOGOOD, IRG ;
RICE, MS ;
JUREIDINI, KF ;
HOGG, RJ ;
BARRETT, LJ .
MEDICAL AND PEDIATRIC ONCOLOGY, 1983, 11 (03) :218-219
[32]   NORMAL COMPUTED TOMOGRAMS OF THE BRAIN IN OSTEO-SARCOMA PATIENTS TREATED WITH HIGH-DOSE METHOTREXATE [J].
BOWLES, D ;
PRATT, C ;
EVANS, W ;
PRICE, RA ;
COBURN, T .
CANCER, 1981, 47 (07) :1762-1765
[33]   PHASE II EVALUATION OF THE COMBINATION OF TRIAZINATE, CYCLOPHOSPHAMIDE, DOXORUBICIN, AND CIS-DIAMMINEDICHLOROPLATINUM(II) IN PATIENTS WITH ADVANCED ADENOCARCINOMA OF THE LUNG [J].
EAGAN, RT ;
FRYTAK, S ;
INGLE, JN ;
CREAGAN, ET ;
NICHOLS, WC ;
KVOLS, LK .
CANCER TREATMENT REPORTS, 1980, 64 (8-9) :925-928
[34]   MULTIPLE MECHANISMS OF CIS-DIAMMINEDICHLOROPLATINUM(II) RESISTANCE IN A MURINE LEUKEMIA-L1210 CELL-LINE [J].
RICHON, VM ;
CODAY, NA ;
EASTMAN, A .
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 :291-291
[35]   CONCOMITANT RADIATION-THERAPY AND CIS-DIAMMINEDICHLOROPLATINUM(II) IN PATIENTS WITH ADVANCED HEAD AND NECK-CANCER [J].
CREAGAN, ET ;
FOUNTAIN, KS ;
FRYTAK, S ;
DESANTO, LW ;
EARLE, JD .
MEDICAL AND PEDIATRIC ONCOLOGY, 1981, 9 (02) :119-120
[36]   OSTEO-SARCOMA - CONTROL OF THE PRIMARY TUMOR WITH INTRA-ARTERIAL CIS-DIAMMINEDICHLORO PLATINUM-II (IACDP) [J].
JAFFE, N ;
CHUANG, V ;
WALLACE, S ;
AYALA, A ;
MURRAY, J ;
ROMSDAHL, M ;
BENJAMIN, RS .
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR) :197-197
[37]   ADRIAMYCIN (ADR) AND CIS-DIAMMINEDICHLOROPLATINUM(II) (CDDP) IN ADVANCED GENITOURINARY (GU) NEOPLASMS WITH POOR RENAL-FUNCTION [J].
KWONG, RW ;
KENNEDY, BJ .
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR) :317-317
[38]   TISSUE DISTRIBUTION OF CIS-DIAMMINEDICHLOROPLATINUM(II) FOLLOWING INTRAPERITONEAL ADMINISTRATION TO PATIENTS WITH RECURRENT GASTRIC-CANCER [J].
KUSUMOTO, T ;
MAEHARA, Y ;
SAKAGUCHI, Y ;
KAKEJI, Y ;
NOHZUKA, T ;
FURUSAWA, M ;
SUGIMACHI, K .
ONCOLOGY, 1993, 50 (04) :214-217
[39]   ABROGATION OF SUPPRESSOR CELLS ACTIVITY BY CIS-DIAMMINEDICHLOROPLATINUM (CDDP) TREATMENT USING THERAPEUTIC DOSES IN OVARIAN-CANCER PATIENTS [J].
TSUDA, H ;
KITAHASHI, S ;
UMESAKI, N ;
KANAOKA, Y ;
KAWABATA, M ;
OGITA, S .
GYNECOLOGIC ONCOLOGY, 1994, 52 (02) :218-221
[40]   CUMULATIVE EFFECT OF CIS-DIAMMINEDICHLOROPLATINUM-II (CDP) ON RENAL-FUNCTION IN PEDIATRIC-PATIENTS WITH OSTEOSARCOMA [J].
JAFFE, N ;
KEIFER, R ;
WANG, YM ;
CANGIR, A ;
ROBERTSON, R .
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 :285-285
12345